FOXO4 and gastric cancer: (76) used univariate and multivariate Cox proportional-hazards models to assess survival risk factors and further verified the aforementioned results in cohorts from The Cancer Genome Atlas, demonstrating that FOXO4 could independently predict the overall survival of patients with gastric cancer.